Security key
82835W108
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)
CUSIP: 82835W108
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 99,255,583
- Total 13F shares
- 63,765,651
- Share change
- +1,343,166
- Total reported value
- $925,913,322
- Put/Call ratio
- 68%
- Price per share
- $14.50
- Number of holders
- 148
- Value change
- +$31,092,478
- Number of buys
- 103
- Number of sells
- 34
Report period
Q3 2024
Institutions
148
Top holders
10
SPRY full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
ARS Pharmaceuticals, Inc. SEC filings
ARS Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 82835W108
Recent filing periods:
Top shareholders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
11%
|
11,077,927
|
$94,273,159 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
11%
|
10,860,977
|
$92,426,914 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
9.3%
|
9,240,887
|
$78,639,948 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.1%
|
4,084,339
|
$34,757,725 | — | 30 Jun 2024 | |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
4%
|
4,012,903
|
$34,149,805 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
3,250,927
|
$27,665,389 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3%
|
2,950,963
|
$25,112,696 | — | 30 Jun 2024 | |
| K2 PRINCIPAL FUND, L.P. |
13F
|
Company |
2.5%
|
2,461,672
|
$20,948,829 | — | 30 Jun 2024 | |
| Nextech Invest Ltd. |
13F
|
Company |
1.9%
|
1,910,029
|
$16,254,347 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.9%
|
1,856,221
|
$15,796,441 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,195,878
|
$10,178,456 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
1.1%
|
1,085,318
|
$9,236,056 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.87%
|
867,319
|
$7,380,885 | — | 30 Jun 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.65%
|
645,700
|
$5,494,907 | — | 30 Jun 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
0.64%
|
639,203
|
$5,439,618 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.44%
|
440,739
|
$3,750,689 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.42%
|
420,575
|
$3,579,093 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.42%
|
415,530
|
$3,536,160 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.37%
|
365,027
|
$3,106,380 | — | 30 Jun 2024 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.29%
|
287,596
|
$2,447,442 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.28%
|
281,144
|
$2,392,535 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.27%
|
267,571
|
$2,277,029 | — | 30 Jun 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.24%
|
239,194
|
$2,035,541 | — | 30 Jun 2024 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.24%
|
236,937
|
$2,016,334 | — | 30 Jun 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.22%
|
217,864
|
$1,854,023 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.19%
|
192,448
|
$1,637,733 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.16%
|
154,434
|
$1,314,233 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
139,285
|
$1,185,313 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
133,806
|
$1,138,688 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.13%
|
124,100
|
$1,056,091 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.12%
|
116,883
|
$994,674 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.12%
|
114,374
|
$973,323 | — | 30 Jun 2024 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.11%
|
111,592
|
$950,000 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.11%
|
108,074
|
$919,710 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.1%
|
97,803
|
$832,304 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.09%
|
90,758
|
$772,351 | — | 30 Jun 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.09%
|
85,317
|
$726,048 | — | 30 Jun 2024 | |
| LEVIN CAPITAL STRATEGIES, L.P. |
13F
|
Company |
0.08%
|
83,250
|
$708,458 | — | 30 Jun 2024 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.08%
|
75,604
|
$643,390 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.07%
|
73,660
|
$626,847 | — | 30 Jun 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.07%
|
71,499
|
$608,456 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.07%
|
68,233
|
$580,663 | — | 30 Jun 2024 | |
| FAS Wealth Partners, Inc. |
13F
|
Company |
0.07%
|
67,656
|
$575,753 | — | 30 Jun 2024 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
66,000
|
$561,660 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
65,942
|
$561,158 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
64,922
|
$552,486 | — | 30 Jun 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.06%
|
58,979
|
$502,000 | — | 30 Jun 2024 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.05%
|
52,814
|
$449,447 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
46,924
|
$399,323 | — | 30 Jun 2024 | |
| Permanent Capital Management, LP |
13F
|
Company |
0.04%
|
42,623
|
$743,771 | — | 30 Jun 2024 |
Institutional Holders of ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) as of Q3 2024
As of 30 Sep 2024,
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) was held by
148 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,765,651 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, BlackRock, Inc., SR One Capital Management, LP, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and Nextech Invest Ltd..
This page lists
148
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
112
Q3 2024 holders
148
Holder diff
36
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.